A 6-year prospective study on new onset diabetes mellitus, insulin release and insulin sensitivity in renal transplant recipients
|
|
- Horatio Shaw
- 5 years ago
- Views:
Transcription
1 Nephrol Dial Transplant (2003) 18: DOI: /ndt/gfg338 Original Article A 6-year prospective study on new onset diabetes mellitus, insulin release and insulin sensitivity in renal transplant recipients Monica Hagen 1, Jøran Hjelmesæth 1, Trond Jenssen 1, Lars Mørkrid 2 and Anders Hartmann 1 1 Department of Medicine, Section of Nephrology and 2 Department of Clinical Chemistry, Rikshospitalet, Oslo, Norway Abstract Background. It is well known that both insulin resistance and insulin deficiency are involved in the pathogenesis of post-transplant diabetes mellitus (PTDM), but the relative importance of the two different mechanisms is still under debate. The present prospective longitudinal study was performed over 6 years to investigate the impact of impaired insulin secretion (ISec) and insulin sensitivity (IS) in the development of PTDM in renal transplant recipients. Methods. A total of 95 non-diabetic patients underwent a 75 g oral glucose tolerance test (OGTT) 10 weeks post-transplant. Six years later, 63 of these recipients were re-examined, the majority (n ¼ 58) with an OGTT. Fasting, 1- and 2-h insulin and glucose levels were measured and used to estimate the insulin secretory response and IS both at baseline and at follow-up. Results. The proportion of recipients with normal glucose tolerance (NGT) rose from 46% (baseline) to 65% (follow-up) (P ¼ 0.008), and median fasting and 2-h serum glucose were reduced by 0.7 mmol/l (P < 0.001) and 1.3 mmol/l (P ¼ 0.039), respectively. The recipients with PTDM at follow-up had a significant decline in the estimated median first and second phase ISec ( 58 and 47%, respectively, P ¼ for both). The patients who normalized their glucose tolerance from PTDM or IGT at baseline to NGT at follow-up increased their IS significantly (68%, P ¼ 0.002) without significant alterations in ISec. Conclusions. Impaired ISec seems to be the dominant mechanism in the development of PTDM after renal transplantation. In contrast, normalization of glucose intolerance is associated with improved IS. Correspondence and offprint requests to: Monica Hagen, Department of Medicine, Section of Nephrology, Laboratory for Renal Physiology, Rikshospitalet, 0027 Oslo, Norway. monica.hagen@rikshospitalet.no Keywords: insulin release; insulin sensitivity; posttransplant diabetes mellitus; renal transplantation Introduction Post-transplant diabetes mellitus (PTDM) and impaired glucose tolerance (IGT) are common complications after renal transplantation [1 3]. Both fasting and post-prandial hyperglycaemia may lead to microvascular complications as well as acceleration of macrovascular disease [4,5]. Impaired insulin secretion (ISec) and peripheral insulin resistance have both been identified as potential mechanisms in the pathogenesis of PTDM. It has been argued that the former may be more important than the latter [6]. We have shown recently that defects in insulin release as assessed 10 weeks after renal transplantation indicate a poor prognosis regarding normalization of glucose tolerance during the following year [7]. Moreover, in non-transplanted type 2 diabetics, like the Pima Indians, worsening of glucose tolerance from normal glucose tolerance (NGT) to IGT, and from IGT to diabetes mellitus, is accompanied by a progressive decline in the acute insulin secretory response and an increase in body weight [8]. In contrast, the subjects who remain normoglycaemic over time are characterized by maintained acute insulin response and glucose disposal. Long-term studies of renal transplant patients are scarce, still questioning whether PTDM may persist over several years in these patients, and whether lateonset diabetes may develop in the individuals who are normoglycaemic shortly after transplantation. The objectives of the present single-centre prospective observational study were first, to assess the glucose tolerance and the occurrence of PTDM in a group of renal transplant recipients over a period of 6 years after transplantation. Secondly, we tested the hypothesis of whether impaired insulin release is more important than insulin resistance in the development of PTDM. ß 2003 European Renal Association European Dialysis and Transplant Association
2 Diabetes mellitus after renal transplantation 2155 Subjects and methods Immunosuppressive therapy Subjects In 1995, 95 Caucasian renal transplant recipients underwent a 75 g oral glucose tolerance test (OGTT) 10 weeks after transplantation. None of these had diabetes prior to transplantation [2]. Six years later, the recipients in this cohort were evaluated for inclusion in the follow-up study. Eighteen patients had died, two had been retransplanted, two were in dialysis and 10 declined to participate, leaving a total of 63 patients to be included in the follow-up study (Figure 1). Each subject gave informed written consent before participating in the study, which was approved by the Regional Committee for Medical Research Ethics, Healthregion South, Norway. Out of 63 patients, 58 were re-examined with an OGTT, the majority (n ¼ 54) at our centre. The glucose challenge was not performed in five recipients, due to manifest PTDM treated with insulin (n ¼ 4) and lack of patient compliance (n ¼ 1). The OGTT was carried out after an overnight fast and included measurements of fasting, 1- and 2-h insulin and glucose concentrations. There were no statistically significant differences between the recipients included in the study and those who were lost to follow-up in terms of gender, age, blood pressure, use of antihypertensive and immunosuppressive medication, glucose tolerance, serum creatinine and number of rejection episodes. Stratification of the patients The recipients were divided into different categories of glucose tolerance according to the criteria given by the Expert Committee [4]: PTDM with fasting serum glucose 7.0 mmol/l or 2-h serum glucose 11.1 mmol/l; IGT with fasting glucose <7.0 mmol/l and 2-h glucose mmol/l; impaired fasting glucose (IFG) with fasting glucose mmol/l and 2-h glucose <7.8 mmol/l; and NGT with fasting serum glucose <6.1 mmol/l and 2-h serum glucose <7.8 mmol/l. Ten weeks after renal transplantation, all patients (n ¼ 63) were treated with prednisolone and cyclosporin A (CsA) (Sandimmun Neoral Õ ), and 81% with azathioprine. During the follow-up period, six recipients were switched to tacrolimus and two to mycophenolate mofetil, and three patients had their prednisolone treatment withdrawn. Excluding the subjects who changed immunosuppressive therapy from the statistical analyses did not change the overall findings. Analytical procedures The analysis of baseline serum glucose was performed using a glucose dehydrogenase method (Cobas Mira, Roche, Switzerland). At follow-up, whole blood glucose was measured with a HemocueAB Õ B-glucose Analyser (Angelholm, Sweden) in 54 recipients, whereas glucose was analysed in venous serum directly in nine recipients. Whole blood glucose values were recalculated to venous serum values [9]. Serum insulin was determined by a commercial radioimmunoassay (Coat-A-Count TM, Diagnostic Products Corporation, Los Angeles, CA) at baseline and by a fluoroimmunoassay (Auto DELFIA TM Insulin, Wallac Oy, Turku, Finland) at follow-up. Creatinine clearance was calculated according to the Cockcroft and Gault formula [10]. Insulin release and sensitivity indices Insulin release was estimated by the use of three OGTTderived indices. These equations have been validated in patients with varying degrees of glucose tolerance and correlate well with the results from hyperglycaemic clamp studies [11,12]. Using the trapezoid rule, the area under the curve (AUC) insulin and the AUC glucose during the OGTT were calculated and implemented in the insulin release index: Secr AUC ¼ AUC Ins /AUC Gluc [11,12]. The first and second phase insulin release were estimated according to the following equations: Secr 1.phase ¼ 1194 þ Ins Gluc 1 þ Ins 1 ;Secr 2.phase ¼ 295 þ Ins Gluc 1 þ Ins 0, where Ins 0 and Ins 1 are serum insulin levels at 0 and 1 h after an OGTT, respectively, and Gluc 1 represents serum glucose 1 h post-load [12]. The OGTT-derived insulin sensitivity (IS) index [ISI TX ¼ body mass index (BMI) Ins Gluc 2 ], which is a modification of the IS index proposed by Stumvoll et al. [12], was implemented as the surrogate estimate of IS [11,13]. The ISI TX has recently been validated in renal transplant recipients and correlated closely with the results from hyperinsulinaemic euglycaemic clamp (r ¼ 0.58, P < 0.001) [13]. Fig. 1. Flow chart of patient inclusion. Statistical analyses Results are given as median and range. For continuous data, the Mann Whitney or the Wilcoxon matched pairs signed rank sum test was used, whereas Pearson 2 or McNemar s test was implemented for categorical data as appropriate. Linear regression was implemented in the analysis of potential independent continuous variables, with 2-h serum glucose or IS as the dependent variables. Multiple linear regression was used to assess any independent predictor of change in glucose
3 2156 M. Hagen et al. tolerance or IS. All variables associated with 2-h serum glucose or IS in the univariate analyses with P-values <0.1 were included in the multiple regression model. Two tailed P-values are reported, and values <0.05 considered significant. The analyses were performed using the Statistical Package for the Social Sciences (SPSS version 10.0 for Windows, Chicago, IL). Results Changes in glucose tolerance from baseline to follow-up The prevalence of PTDM, IGT and NGT at baseline and follow-up is shown in Figure 2. The proportion of recipients with NGT rose from 46 to 65% during the 6 years (P ¼ 0.008). At baseline, 12 recipients (19%) had PTDM, IGT was found in 22 recipients (35%) whereas 29 patients (46%) had NGT. At follow-up, 14 recipients (22%) had PTDM, eight recipients (13%) had IGT and 41 patients (65%) had NGT. None of the patients had IFG, either at baseline or at follow-up. Five out of 12 patients with diabetes at baseline improved to NGT (n ¼ 4) or IGT (n ¼ 1) during the follow-up period. Among the 22 recipients with IGT at baseline, 11 patients improved to NGT, whereas six progressed to PTDM. One recipient with NGT at baseline deteriorated to PTDM during the follow-up period. The majority (26 out of 29) of the patients with NGT 10 weeks after renal transplantation were still euglycaemic 6 years later. In the total patient population, median fasting (P < 0.001) and 2-h (P ¼ 0.039) serum glucose were Fig. 2. Changes in glucose tolerance category from baseline (10 weeks) to follow-up 6 years after renal transplantation. PTDM, post-transplant diabetes mellitus; IGT, impaired glucose tolerance; NGT, normal glucose tolerance. significantly lower 6 years after renal transplantation as compared with baseline (Table 1). This coincided with a 50% decrease in median daily prednisolone dose and CsA whole blood trough concentration, a significant increase in median BMI and a decrement in median serum triglyceride concentration. The renal function improved slightly from baseline to follow-up. When the change in 2-h serum glucose was considered as being the dependent variable, univariate linear regression analysis showed a significant association between reduction in daily prednisolone dose and improvement in glucose tolerance ( ¼ 0.12, r 2 ¼ 0.069, P ¼ 0.046). On the other hand, neither the increase in BMI nor the decline in CsA whole blood trough concentration were associated with an alteration in glucose tolerance. Hypoglycaemic therapy Seven recipients had PTDM both at baseline and at follow-up. Of these, two patients were treated with insulin both at baseline and at follow-up, one recipient was switched from glipizide to insulin during the period and one had metformin withdrawn. The three remaining subjects were not treated with any hypoglycaemic drugs, either at baseline or at follow-up. None of the five recipients who improved their glucose tolerance from PTDM to either IGT (n ¼ 1) or NGT (n ¼ 4) were on glucose-lowering drugs at baseline. One recipient, who deteriorated from IGT to PTDM, was on a combination treatment with insulin and metformin at follow-up. None of the recipients who were using hypoglycaemic therapy at follow-up went through the OGTT. Insulin secretion (ISec) and insulin sensitivity (IS) Calculated indices of ISec and IS for all recipients are given in Table 2. All the indices of ISec were significantly reduced 6 years after renal transplantation (Secr 1.phase, P < 0.001; Secr 2.phase, P < 0.001; Secr AUC, P < 0.001), whereas median IS increased significantly (ISI TX, P ¼ 0.033). The changes in BMI and IS from baseline to followup were inversely correlated in the univariate model (linear regression: ¼ 0.006, r 2 ¼ 0.262, P < 0.001), whereas the reduction in median daily prednisolone dose and triglyceride level tended to be associated with improved insulin action ( ¼ 0.001, r 2 ¼ 0.067, P ¼ and ¼ 0.008, r 2 ¼ 0.057, P ¼ 0.098, respectively). When the change in prednisolone dose, triglyceride concentration and BMI were included in a multiple linear regression model, dose reduction of prednisolone was significantly associated with improved IS, whereas an increase in BMI was associated with a reduction in IS (P < for both, r 2 ¼ 0.34). Serum triglycerides were, on the other hand, not related to changes in IS in this model. None of these parameters were associated with changes in ISec.
4 Diabetes mellitus after renal transplantation 2157 Table 1. Changes in serum glucose, body weight, renal function, immunosuppressive and antihypertensive therapy during the first 6 years after renal transplantation (n ¼ 63) Baseline Follow-up Difference (%) P Serum glucose (mmol/l) Fasting 5.4 ( ) 4.7 ( ) 0.7 ( 13) < h 7.9 ( ) 6.6 ( ) 1.3 ( 16) Prednisolone dose (mg/day) 10 (10 30) 5 (0 10) 5 ( 50) <0.001 CsA trough concentration (mg/l) 255 ( ) 120 (35 215) 135 ( 53) <0.001 Creatinine (mmol/l) 136 (81 350) 130 (68 363) 6 ( 4) Creatinine clearance (ml/min) 55 (20 109) 60 (13 135) 5 (9) Body weight (kg) 69 (43 117) 73 (47 142) 4 (6) <0.001 BMI (kg/m 2 ) 22.8 ( ) 24.3 ( ) 1.5 (7) <0.001 Triglycerides (mmol/l) 1.9 ( ) 1.4 ( ) 0.5 ( 26) <0.001 Number of patients using Furosemide 20 (32%) 19 (30%) 1 ( 5) >0.9 -Blocker 25 (40%) 25 (40%) 0 (0) >0.9 Values are presented as median (range). Statistics: Wilcoxon matched pairs signed rank sum- or McNemar s test as appropriate. Table 2. Changes in estimated insulin secretion and insulin sensitivity during the first 6 years after renal transplantation (n ¼ 55) Association of changes in ISec and IS with changes in glucose tolerance 6 years after renal transplantation To assess the relative importance of ISec and IS on changes in glucose tolerance during the follow-up, the recipients were divided into two groups (Table 3). The group of patients who had PTDM at follow-up (n ¼ 14) was labelled diabetic. The group of recipients who normalized their glucose tolerance, from PTDM or IGT at baseline to NGT at follow-up (n ¼ 15), was labelled normoglycaemic. At baseline, these two groups were not significantly different in terms of IS, ISec, BMI, fasting and post-prandial serum glucose, kidney function and treatment with antihypertensive medication (P > 0.117). The diabetic group had a decline in estimated median insulin release of 58% (Secr 1.phase ) and 47% (Secr 2.phase ), whereas the ISI TX did not change significantly (Table 3). In contrast, the median ISI TX increased significantly (68%; P ¼ 0.002) whereas the median first and second phase insulin release were unchanged in the normoglycaemic group. The patients who had NGT both at baseline and at follow-up (n ¼ 26) tended to increase their IS [8.8 ( ) vs 9.3 ( ) 10 2 ; P ¼ 0.101]. All the ISec indices were significantly reduced during the period (P < 0.001). Baseline Follow-up Difference (%) P Insulin secretion indices Secr 1.phase 1293 ( 262 to 4537) 905 ( 448 to 3001) 388 ( 30) <0.001 Secr 2.phase 339 ( 7 to 1134) 245 ( 61 to 751) 94 ( 28) <0.001 Secr AUC 44 (10 159) 28 (7 124) 16 ( 36) <0.001 Insulin sensitivity index ISI TX ( 1.0 to 12.0) 9.1 ( 2.0 to 13.0) 1.8 (25) Values are presented as median (range). Statistics: Wilcoxon matched pairs signed rank sum test. Discussion Glucose tolerance In general, median fasting and 2-h serum glucose values declined significantly from baseline to follow-up. One half of the recipients with IGT and one-third of the recipients with PTDM improved to NGT. The recipients with PTDM who improved their glucose tolerance were not on glucose-lowering therapy at baseline. The majority of the recipients with NGT at baseline remained normoglycaemic after 6 years. Thus, NGT shortly after renal transplantation indicates a favourable prognosis for normoglycaemia in the long term [3]. On the other hand, about half (n ¼ 7) of the patients with PTDM at follow-up were diabetic already 10 weeks after transplantation. The other half (n ¼ 6) were mainly patients with IGT in the early course who progressed to PTDM, which supports the idea that IGT early after renal transplantation represents a risk factor for later development of PTDM [14,15]. Insulin sensitivity The IS improved significantly in the cohort in general over the 6 years. We previously have reported that tapering off prednisolone during the first year after renal transplantation is significantly associated with
5 2158 M. Hagen et al. Table 3. Changes in estimated insulin secretion and insulin sensitivity, BMI and daily prednisolone dose according to changes in glucose tolerance Diabetic a (n ¼ 14) Normoglycaemic b (n ¼ 15) Baseline Follow-up Difference (%) P Baseline Follow-up Difference (%) P Insulin secretion indices Secr 1.phase 858 ( ) 359 ( 448 to 914) 499 ( 58) ( ) 1000 ( ) 88 ( 8) Secr2.phase 239 (63 451) 127 ( 61 to 257) 112 ( 47) ( ) 266 (90 650) 31 ( 10) SecrAUC 30 (14 59) 25 (6 57) 5 ( 17) (19 159) 32 (15 117) 11 ( 26) Insulin sensitivity index ISI TX ( ) 5.8 ( ) 1.4 ( 19) ( 1.0 to 10.1) 9.6 ( 0.3 to 12.3) 3.9 (68) BMI (kg 2 /m) 22.9 ( ) 24.5 ( ) 1.6 (7) ( ) 23.8 ( ) 1.1 (5) Prednisolone (mg/day) 10 (10 30) 5 (0 10) 5 ( 50) (10 30) 5 (5 10) 10 ( 67) Triglycerides (mmol/l) 2.0 ( ) 1.4 ( ) 0.6 ( 30) ( ) 1.3 ( ) 0.9 ( 41) Values are presented as median (range). a Diabetic: Patients with PTDM at follow-up, who either stayed diabetic or progressed to PTDM from IGT or NGT. b Normoglycaemic: patients with PTDM or IGT at baseline who normalized their glucose tolerance (NGT) till follow-up. Statistics: Wilcoxon matched pairs signed rank sum test. improved glucose tolerance [3]. The present findings of a significant association between prednisolone tapering and improvement in IS may explain and support our previous data [3]. The group of recipients with PTDM or IGT at baseline who normalized their glucose tolerance was characterized by a significant increase in IS and preserved ISec. Interestingly, they also used higher daily doses of prednisolone than the progressors did in the early course. The subsequent greater dose reduction can be one plausible explanation for the improvement in IS [3]. Furthermore, hyperglycaemia itself predisposes for insulin resistance [16] and, as these patients gradually became normoglycaemic, they may have improved their IS by reducing the glucose exposure in insulin-sensitive tissue. However, the weight gain in both groups may have counteracted the improvement in IS. Insulin secretion The OGTT-derived first and second phase ISec decreased by half in the total patient population. Older age is known to be an important determinant of impaired -cell function [2,17]. However, we were not able to show a significant association between estimated ISec and age in the present study (data not shown). Since the glucose tolerance was improved during the period, the reduction in ISec seems mainly to be caused by increased IS. It is widely believed that diminution of first phase ISec is the earliest detectable defect of -cell function in the non-transplant human population [18]. Further, in the Pima Indians, the reduction in ISec is more pronounced than the fall in IS among subjects developing type 2 diabetes [9]. In the present study, the group of patients who developed PTDM during the follow-up suffered from a steep decline in ISec. Both the estimated acute and late phase insulin responses were diminished to a similar degree (Table 3). Thus, impaired ISec seems to be a prerequisite for the development of both PTDM and type 2 diabetes. A positive family history of diabetes is well known to be associated with increased risk of developing IGT [2,18,19]. The inability of the -cells to compensate for a decrease in insulin action distinguishes individuals who develop diabetes from those who retain NGT [18]. Five of the 14 diabetic recipients at follow-up reported diabetes mellitus in first-degree relatives, whereas this was the case in only one of the 15 non-diabetics. The immunosuppressive therapy, and particularly high doses of steroids in the early course, has probably revealed early glucose intolerance in predisposed pre-transplant non-diabetic individuals [2,6,13,20]. Although it has been suggested that the mechanism behind the diabetogenic effect of CsA is impaired insulin release, we were not able to find any association between the change in whole blood CsA trough levels and the change in estimated insulin secretion from baseline to follow-up. If any such an effect exists, it cannot be strictly dose dependent [3].
6 Diabetes mellitus after renal transplantation 2159 A limitation of the present study is that the surrogate estimates for ISec and IS may be inferior compared with insulin measures derived from hyperglycaemic and euglycaemic clamp studies. However, the ISec indices have been validated extensively in patients with different degrees of glucose tolerance and are strongly correlated with results from clamp studies [11,12]. In addition, the ISI TX has recently been validated in renal transplant subjects and found to correlate well with results from hyperinsulinaemic euglycaemic clamp [13]. Moreover, one should be aware that 32 patients were lost to follow-up, of whom 18 died. We do not know the glucose tolerance status of these recipients over the years. This may have biased our conclusions on the transitions between normoglycaemia and hyperglycaemia in the cohort. However, the fact that the persons lost to follow-up were not significantly different from the subjects included in the study at baseline makes it less likely that this is a major flaw of the study. In conclusion, a decline in insulin secretion seems to be the most important factor for the development of long-term PTDM. On the other hand, improvement in insulin sensitivity together with sufficient insulin release is associated with improved glucose tolerance during the first 6 years after renal transplantation. Acknowledgements. We appreciate the skilled technical assistance provided by Jean Stenstrøm, Kirsten Lund, Janicke Narverud and Els Breistein in the Laboratory for Renal Physiology. This study was financed by grants from the Norwegian Foundation for Health and Rehabilitation, the Norwegian Research Council and the Laboratory for Renal Physiology at Rikshospitalet. Conflict of interest statement. None declared. References 1. Jindal RM. Posttransplant diabetes mellitus a review. Transplantation 1994; 58: Hjelmesaeth J, Hartmann A, Kofstad J et al. Glucose intolerance after renal transplantation depends upon prednisolone dose and recipient age. Transplantation 1997; 64: Hjelmesaeth J, Hartmann A, Kofstad J, Egeland T, Stenstrom J, Fauchald P. Tapering off prednisolone and cyclosporine the first year after renal transplantation: the effect on glucose tolerance. Nephrol Dial Transplant 2001; 16: Expert Committee on Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2000; 23: S4 S19 5. de Vegt F, Dekker JM, Ruhe HG et al. Hyperglycaemia is associated with all-cause and cardiovascular mortality in the Hoorn population: the Hoorn Study. Diabetologia 1999; 42: Nam JH, Mun JI, Kim SI et al. -Cell dysfunction rather than insulin resistance is the main contributing factor for the development of postrenal transplantation diabetes mellitus. Transplantation 2001; 71: Hjelmesaeth J, Hagen M, Hartmann A, Midtvedt K, Egeland T, Jenssen T. The impact of impaired insulin release and insulin resistance on glucose intolerance after renal transplantation. Clin Transplant 2002; 16: Weyer C, Bogardus C, Mott DM, Pratley RE. The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest 1999; 104: Stahl M, Brandslund I, Jorgensen LG, Hyltoft Petersen P, Borch-Johnsen K, de Fine Olivarius N. Can capillary whole blood glucose and venous plasma glucose measurements be used interchangeably in diagnosis of diabetes mellitus? Scand J Clin Lab Invest 2002; 62: Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: Stumvoll M, Mitrakou A, Pimenta W et al. Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care 2000; 23: Stumvoll M, Van Haeften T, Fritsche A, Gerich J. Oral glucose tolerance test indexes for insulin sensitivity and secretion based on various availabilities of sampling times. Diabetes Care 2001; 24: Hjelmesaeth J, Midtvedt K, Jenssen T, Hartmann A. Insulin resistance after renal transplantation: impact of immunosuppressive and antihypertensive therapy. Diabetes Care 2001; 24: Jarrett RJ, Keen H, McCartney P. The Whitehall Study: ten year follow-up report on men with impaired glucose tolerance with reference to worsening to diabetes and predictors of death. Diabet Med 1984; 1: Hjelmesaeth J, Hartmann A, Midtvedt K et al. Metabolic cardiovascular syndrome after renal transplantation. Nephrol Dial Transplant 2001; 16: Yki-Järvinen H. Glucose toxicity. Endocr Rev 1992; 13: Chiu KC, Lee NP, Cohan P, Chuang LM. Beta cell function declines with age in glucose tolerant Caucasians. Clin Endocrinol 2000; 53: Gerich JE. Is reduced first-phase insulin release the earliest detectable abnormality in individuals destined to develop type 2 diabetes? Diabetes 2002; 51: S117 S Aitman TJ, Todd JA. Molecular genetics of diabetes mellitus. Baillieres Clin Endocrinol Metab 1995; 9: Henriksen JE, Alford F, Ward GM, Beck-Nielsen H. Risk and mechanism of dexamethasone-induced deterioration of glucose tolerance in non-diabetic first-degree relatives of NIDDM patients. Diabetologia 1997; 40: Received for publication: Accepted in revised form:
Validation of diagnostic utility of fasting plasma glucose and HbA1c in stable renal transplant recipients one year after transplantation
Ussif et al. BMC Nephrology (2019) 20:12 https://doi.org/10.1186/s12882-018-1171-3 RESEARCH ARTICLE Open Access Validation of diagnostic utility of fasting plasma glucose and HbA1c in stable renal transplant
More informationThe association of early post-transplant glucose levels with long-term mortality
Diabetologia (2011) 54:1341 1349 DOI 10.1007/s00125-011-2105-9 ARTICLE The association of early post-transplant glucose levels with long-term mortality T. G. Valderhaug & J. Hjelmesæth & A. Hartmann &
More informationThe impact of short-term ciclosporin A treatment on insulin secretion and insulin sensitivity in man
Nephrol Dial Transplant (2007) 22: 1743 1749 doi:10.1093/ndt/gfl820 Advance Access publication 13 February 2007 Original Article The impact of short-term ciclosporin A treatment on insulin secretion and
More informationAdeterioration in -cell function is an independent
Relationships Among Age, Proinsulin Conversion, and -Cell Function in Nondiabetic Humans Andreas Fritsche, Alexander Madaus, Norbert Stefan, Otto Tschritter, Elke Maerker, Anna Teigeler, Hans Häring, and
More informationHenrik Andreas Bergrem. Hyperglycaemia before and after renal transplantation
Henrik Andreas Bergrem Hyperglycaemia before and after renal transplantation Faculty of Medicine University of Oslo 2010 Henrik Andreas Bergrem, 2010 Series of dissertations submitted to the Faculty of
More informationGlucagon secretion in relation to insulin sensitivity in healthy subjects
Diabetologia (2006) 49: 117 122 DOI 10.1007/s00125-005-0056-8 ARTICLE B. Ahrén Glucagon secretion in relation to insulin sensitivity in healthy subjects Received: 4 July 2005 / Accepted: 12 September 2005
More informationAssessment of glomerular filtration rate in healthy subjects and normoalbuminuric diabetic patients: validity of a new (MDRD) prediction equation
Nephrol Dial Transplant (2002) 17: 1909 1913 Original Article Assessment of glomerular filtration rate in healthy subjects and normoalbuminuric diabetic patients: validity of a new () prediction equation
More informationDe novo posttransplant diabetes mellitus (PTDM) occurs
CLINICAL TRAPLANTATION Home Glucometer Monitoring Markedly Improves Diagnosis of Post Renal Transplant Diabetes Mellitus in Renal Transplant Recipients Amish Shah, 1 Gwen Kendall, 1 Richard A. Demme, 1
More informationBK virus infection in renal transplant recipients: single centre experience. Dr Wong Lok Yan Ivy
BK virus infection in renal transplant recipients: single centre experience Dr Wong Lok Yan Ivy Background BK virus nephropathy (BKVN) has emerged as an important cause of renal graft dysfunction in recent
More informationDiabetes Care 24:89 94, 2000
Pathophysiology/Complications O R I G I N A L A R T I C L E Insulin Resistance and Insulin Secretory Dysfunction Are Independent Predictors of Worsening of Glucose Tolerance During Each Stage of Type 2
More informationConcordance rate for Type II diabetes mellitus in monozygotic twins: actuarial analysis
Diabetologia (1999) 42: 146±150 Ó Springer-Verlag 1999 Concordance rate for Type II mellitus in monozygotic twins: actuarial analysis F. Medici, M. Hawa, A. Ianari, D. A. Pyke, R. D.G Leslie Department
More informationIncreased Early Rejection Rate after Conversion from Tacrolimus in Kidney and Pancreas Transplantation
Increased Early Rejection Rate after Conversion from Tacrolimus in Kidney and Pancreas Transplantation Gary W Barone 1, Beverley L Ketel 1, Sameh R Abul-Ezz 2, Meredith L Lightfoot 1 1 Department of Surgery
More informationIgnell, Claes; Berntorp, Kerstin. Published in: Scandinavian Journal of Clinical & Laboratory Investigation DOI: /
Evaluation of the relationship between capillary and venous plasma glucose concentrations obtained by the HemoCue Glucose 201+ system during an oral glucose tolerance test Ignell, Claes; Berntorp, Kerstin
More informationThe enteroinsular axis in the pathogenesis of prediabetes and diabetes in humans
The enteroinsular axis in the pathogenesis of prediabetes and diabetes in humans Young Min Cho, MD, PhD Division of Endocrinology and Metabolism Seoul National University College of Medicine Plasma glucose
More informationIs Reduced First-Phase Insulin Release the Earliest Detectable Abnormality in Individuals Destined to Develop Type 2 Diabetes?
Is Reduced First-Phase Insulin Release the Earliest Detectable Abnormality in Individuals Destined to Develop Type 2 Diabetes? John E. Gerich Insulin is released from the pancreas in a biphasic manner
More informationNew-onset diabetes after transplantation. Christophe Legendre Université Paris Descartes & Hôpital Necker, Paris.
New-onset diabetes after transplantation Christophe Legendre Université Paris Descartes & Hôpital Necker, Paris. Actualités Jean Hamburger Paris, 23-24 avril 2012 NODAT IFG IGT CJ Yates et al, Am J Transplant
More informationOUT OF DATE. Choice of calcineurin inhibitors in adult renal transplantation: Effects on transplant outcomes
nep_734.fm Page 88 Friday, January 26, 2007 6:47 PM Blackwell Publishing AsiaMelbourne, AustraliaNEPNephrology1320-5358 2006 The Author; Journal compilation 2006 Asian Pacific Society of Nephrology? 200712S18897MiscellaneousCalcineurin
More informationReduced graft function (with or without dialysis) vs immediate graft function a comparison of long-term renal allograft survival
Nephrol Dial Transplant (2006) 21: 2270 2274 doi:10.1093/ndt/gfl103 Advance Access publication 22 May 2006 Original Article Reduced graft function (with or without dialysis) vs immediate graft function
More informationRenal Protection Staying on Target
Update Staying on Target James Barton, MD, FRCPC As presented at the University of Saskatchewan's Management of Diabetes & Its Complications (May 2004) Gwen s case Gwen, 49, asks you to take on her primary
More informationSUMMARY. Introduction. Study design. Summary
SUMMARY Introduction The global prevalence of type 2 diabetes is increasing rapidly and nowadays affects almost 250 million people. Cardiovascular disease is the most prevalent complication of type 2 diabetes,
More informationCan modifications of the MDRD formula improve the estimation of glomerular filtration rate in renal allograft recipients?
Nephrol Dial Transplant (7) 22: 361 3615 doi:1.193/ndt/gfm282 Advance Access publication 22 September 7 Original Article Can modifications of the MDRD formula improve the estimation of glomerular filtration
More informationResearch Article Associated Factors with Biochemical Hypoglycemia during an Oral Glucose Tolerance Test in a Chinese Population
Hindawi Diabetes Research Volume 2017, Article ID 3212814, 5 pages https://doi.org/10.1155/2017/3212814 Research Article Associated Factors with Biochemical Hypoglycemia during an Oral Glucose Tolerance
More informationDiltiazem use in tacrolimus-treated renal transplant recipients Kothari J, Nash M, Zaltzman J, Prasad G V R
Diltiazem use in tacrolimus-treated renal transplant recipients Kothari J, Nash M, Zaltzman J, Prasad G V R Record Status This is a critical abstract of an economic evaluation that meets the criteria for
More informationManagement of Diabetes After Solid Organ Transplantation
Management of Diabetes After Solid Organ Transplantation Aidar R. Gosmanov, MD, PhD, FACE Chief, Endocrinology Section Stratton VAMC, Albany, NY Associate Professor of Medicine Division of Endocrinology,
More informationSELECTED ABSTRACTS. All (n) % 3-year GS 88% 82% 86% 85% 88% 80% % 3-year DC-GS 95% 87% 94% 89% 96% 80%
SELECTED ABSTRACTS The following are summaries of selected posters presented at the American Transplant Congress on May 5 9, 2007, in San Humar A, Gillingham KJ, Payne WD, et al. Review of >1000 kidney
More informationREACH Risk Evaluation to Achieve Cardiovascular Health
Dyslipidemia and transplantation History: An 8-year-old boy presented with generalized edema and hypertension. A renal biopsy confirmed a diagnosis of focal segmental glomerulosclerosis (FSGS). After his
More informationThe role of glycated hemoglobin in the screening and diagnosis of renal posttransplantation diabetes
Federal University of Rio Grande do Sul Graduate Program in Endocrinology Brazil The role of glycated hemoglobin in the screening and diagnosis of renal posttransplantation diabetes Ana Laura Pimentel
More informationN Melchionda 1, G Forlani 1 *, G Marchesini 1, L Baraldi 1 and S Natale 1
(2002) 26, 90 96 ß 2002 Nature Publishing Group All rights reserved 0307 0565/02 $25.00 www.nature.com/ijo PAPER WHO and ADA criteria for the diagnosis of diabetes mellitus in relation to body mass index.
More informationObjectives. Kidney Complications With Diabetes. Case 10/21/2015
Objectives Kidney Complications With Diabetes Brian Boerner, MD Diabetes, Endocrinology, and Metabolism University of Nebraska Medical Center Review screening for, and management of, albuminuria Review
More informationInitiating Insulin in Primary Care for Type 2 Diabetes Mellitus. Dr Manish Khanolkar, Diabetologist, Auckland Diabetes Centre
Initiating Insulin in Primary Care for Type 2 Diabetes Mellitus Dr Manish Khanolkar, Diabetologist, Auckland Diabetes Centre Outline How big is the problem? Natural progression of type 2 diabetes What
More informationOverall and cardiovascular mortality in Norwegian kidney donors compared to the background population
CMV and renal allograft rejection 443 Nephrol Dial Transplant (2012) 27: 443 447 doi: 10.1093/ndt/gfr303 Advance Access publication 2 June 2011 Overall and cardiovascular mortality in Norwegian kidney
More informationCHAPTER 3 DIABETES MELLITUS, OBESITY, HYPERTENSION AND DYSLIPIDEMIA IN ADULT CENTRAL KERALA POPULATION
CHAPTER 3 DIABETES MELLITUS, OBESITY, HYPERTENSION AND DYSLIPIDEMIA IN ADULT CENTRAL KERALA POPULATION 3.1 BACKGROUND Diabetes mellitus (DM) and impaired glucose tolerance (IGT) have reached epidemic proportions
More informationCHAPTER 5 RENAL TRANSPLANTATION. Editor: Dr Goh Bak Leong
CHAPTER 5 RENAL TRANSPLANTATION Editor: Dr Goh Bak Leong Expert Panel: Dr Goh Bak Leong (Chair) Dato Dr (Mr) Rohan Malek Dr Wong Hin Seng Dr Fan Kin Sing Dr Rosnawati Yahya Dr S Prasad Menon Dr Tan Si
More informationPost-challenge hyperglycaemia is associated with premature death and macrovascular complications
Diabetologia (2003) 46[Suppl1]:M17 M21 DOI 10.1007/s00125-002-0932-4 Post-challenge hyperglycaemia is associated with premature death and macrovascular complications Q. Qiao 1, 2, J. Tuomilehto 2, 3, K.
More informationSerum uric acid levels improve prediction of incident Type 2 Diabetes in individuals with impaired fasting glucose: The Rancho Bernardo Study
Diabetes Care Publish Ahead of Print, published online June 9, 2009 Serum uric acid and incident DM2 Serum uric acid levels improve prediction of incident Type 2 Diabetes in individuals with impaired fasting
More informationWORLDWIDE, THE PREVAlence
ORIGINAL CONTRIBUTION Relation of Impaired Fasting and Postload Glucose With Incident Type 2 Diabetes in a Dutch Population The Hoorn Study Femmie de Vegt, PhD Jacqueline M. Dekker, PhD Agnes Jager, MD,
More informationThe impact of metoprolol on insulin sensitivity in the ICU
MCBMS 2009 The impact of metoprolol on insulin sensitivity in the ICU JG Chase et al Dept of Mechanical Engineering Centre for Bio-Engineering University of Canterbury New Zealand Introduction Why do we
More informationA family history of diabetes is associated with reduced physical fitness in the Prevalence, Prediction and Prevention of Diabetes (PPP) Botnia study
Diabetologia (2010) 53:1709 1713 DOI 10.1007/s00125-010-1776-y SHORT COMMUNICATION A family history of diabetes is associated with reduced physical fitness in the Prevalence, Prediction and Prevention
More informationAcute rejection and late renal transplant failure: Risk factors and prognosis
Nephrol Dial Transplant (2004) 19 [Suppl 3]: iii38 iii42 DOI: 10.1093/ndt/gfh1013 Acute rejection and late renal transplant failure: Risk factors and prognosis Luis M. Pallardo Mateu 1, Asuncio n Sancho
More informationComparison of Serum Cystatin C and Creatinine Levels to Evaluate Early Renal Function after Kidney Transplantation
IJMS Vol 34, No 2, June 2009 Original Article Comparison of Serum Cystatin C and Creatinine Levels to Evaluate Early Renal Function after Kidney Transplantation Reza Hekmat, Hamid Eshraghi Abstract Background:
More informationThe term impaired glucose tolerance
Cardiovascular and Metabolic Risk O R I G I N A L A R T I C L E Risk of Progression to Type 2 Diabetes Based on Relationship Between Postload Plasma Glucose and Fasting Plasma Glucose MUHAMMAD A. ABDUL-GHANI,
More informationQuality of sleep in patients with chronic kidney disease
Nephrol Dial Transplant (2004) 19: 95 99 DOI: 10.1093/ndt/gfg423 Original Article Quality of sleep in patients with chronic kidney disease Eduard A. Iliescu, Karen E. Yeates and David C. Holland Department
More informationClinical Study 1-Hour OGTT Plasma Glucose as a Marker of Progressive Deterioration of Insulin Secretion and Action in Pregnant Women
Hindawi Publishing Corporation International Journal of Endocrinology Volume 2012, Article ID 460509, 5 pages doi:10.1155/2012/460509 Clinical Study 1-Hour OGTT Plasma Glucose as a Marker of Progressive
More informationDiabetes Care 32: , 2009
Pathophysiology/Complications O R I G I N A L A R T I C L E Primary Defects in -Cell Function Further Exacerbated by Worsening of Insulin Resistance Mark the Development of Impaired Glucose Tolerance in
More informationCHAPTER 5 RENAL TRANSPLANTATION
CHAPTER 5 RENAL TRANSPLANTATION Editor: Dr. Goh Bak Leong Expert Panel: Dato Dr. Zaki Morad b Mohd Zaher (Chair) Dr. Goh Bak Leong (Co-Chair) Dr. Fan Kin Sing Dr. Lily Mushahar Mr. Rohan Malek Dr. S. Prasad
More informationThe Effect of Lowering the Threshold for Diagnosis of Impaired Fasting Glucose
Yonsei Med J 49(2):217-223, 2008 DOI 10.3349/ymj.2008.49.2.217 The Effect of Lowering the Threshold for Diagnosis of Impaired Fasting Glucose So Hun Kim, 1 Wan Sub Shim, 1 Eun A Kim, 1 Eun Joo Kim, 1 Seung
More informationAntiviral Therapy 13:
Antiviral Therapy 13:1091 1095 Short communication Cystatin C as a marker of renal function is affected by HIV replication leading to an underestimation of kidney function in HIV patients Stefan Mauss
More informationPancreas Transplantation. Sonia Clarke-Swaby Recipient Kidney/pancreas Transplant Co-ordinator Guy s Hospital
Pancreas Transplantation Sonia Clarke-Swaby Recipient Kidney/pancreas Transplant Co-ordinator Guy s Hospital Introduction Selection criteria, New innovation Complications, Success rates, Life expectancy
More informationFasting Plasma Glucose Reference Values among Young Japanese Women Requiring 75g Oral Glucose Tolerance Tests
Tokai J Exp Clin Med., Vol. 34, No. 1, pp. 15-2, 29 Fasting Plasma Glucose Reference Values among Young Japanese Women Requiring 75g Oral Glucose Tolerance Tests Yoko KOIKE *1, Yoichi OGUSHI *2, Dacheng
More informationARTICLE. Caroline K. Kramer & Chang Ye & Anthony J. G. Hanley & Philip W. Connelly & Mathew Sermer & Bernard Zinman & Ravi Retnakaran
Diabetologia (2015) 58:1354 1362 DOI 10.1007/s00125-015-3551-6 ARTICLE Delayed timing of post-challenge peak blood glucose predicts declining beta cell function and worsening glucose tolerance over time:
More informationCHAPTER 14. Renal Transplantation
15th Report of the Malaysian RENAL TRANSPLANTATION CHAPTER 14 Renal Transplantation Editor: Dr. Goh Bak Leong Expert Panel: : Dato Dr. Dato Zaki Dr. Morad Zaik Morad Mohd (Chair) Zaher (Chair) Dr. Goh
More informationGeneral Outline. General Outline. Pathogenesis of Metabolic Dysfunction in Sleep Apnea: The Role of Sleep Fragmentation and Intermittent Hypoxemia
Pathogenesis of Metabolic in Sleep Apnea: The Role of Sleep Fragmentation and Intermittent Hypoxemia Naresh M. Punjabi, MD, PhD Associate Professor of Medicine and Epidemiology Johns Hopkins University,
More informationRisk factors associated with the development of overt nephropathy in type 2 diabetes patients: A 12 years observational study
Indian J Med Res 136, July 2012, pp 46-53 Risk factors associated with the development of overt nephropathy in type 2 diabetes patients: A 12 years observational study Vijay Viswanathan, Priyanka Tilak
More informationEvaluation of a glomerular filtration term in the DISST model to capture the glucose pharmacodynamics of an insulin resistant cohort
Evaluation of a glomerular filtration term in the DISST model to capture the glucose pharmacodynamics of an insulin resistant cohort Paul D Docherty J Geoffrey Chase Thomas F Lotz Jeremy D Krebs Study
More informationSteroid Minimization: Great Idea or Silly Move?
Steroid Minimization: Great Idea or Silly Move? Disclosures I have financial relationship(s) within the last 12 months relevant to my presentation with: Astellas Grants ** Bristol Myers Squibb Grants,
More informationEvaluation of the Cockroft Gault, Jelliffe and Wright formulae in estimating renal function in elderly cancer patients
Original article Annals of Oncology 15: 291 295, 2004 DOI: 10.1093/annonc/mdh079 Evaluation of the Cockroft Gault, Jelliffe and Wright formulae in estimating renal function in elderly cancer patients G.
More informationPretransplant Risk Score for New-Onset Diabetes After Kidney Transplantation
Clinical Care/Education/Nutrition/Psychosocial Research O R I G I N A L A R T I C L E Pretransplant Risk Score for New-Onset Diabetes After Kidney Transplantation HARINI A. CHAKKERA, MD, MPH 1 E. JENNIFER
More informationPost Transplant Diabetes Mellitus in Ahmed Gasim Kidney Transplant Center, Sudan
Arab Journal of Nephrology and Transplantation Original Article AJNT Post Transplant Diabetes Mellitus in Ahmed Gasim Kidney Transplant Center, Sudan Abdul-Rahman A El-Magzoub a*, Sarra Elamin b a. Consultant
More informationCHAPTER 5 RENAL TRANSPLANTATION. Editor: Dr Rosnawati Yahya
CHAPTER 5 Editor: Dr Rosnawati Yahya Expert Panels: Dr Rosnawati Yahya Dr Ng Kok Peng Dr Suryati Binti Yakaob Dr Mohd Zaimi Abd Wahab Dr Yee Seow Ying Dr Wong Hin Seng Contents 5. Stock and Flow of Renal
More informationKidney transplantation in the elderly the Norwegian experience
Nephrol Dial Transplant (2008) 23: 1026 1031 doi: 10.1093/ndt/gfm719 Advance Access publication 13 December 2007 Original Article Kidney transplantation in the elderly the Norwegian experience Kristian
More informationThe evolution of non-diabetic hyperglycemia: a longitudinal study
Endocrine Journal 2014, 61 (1), 91-99 Or i g i n a l The evolution of non-diabetic hyperglycemia: a longitudinal study Rie Oka 1), Kunimasa Yagi 2), Kenshi Hayashi 2), Masa-aki Kawashiri 2), Masakazu Yamagishi
More informationThese results are supplied for informational purposes only.
These results are supplied for informational purposes only. Prescribing decisions should be made based on the approved package insert in the country of prescription Sponsor/company: sanofi-aventis ClinialTrials.gov
More informationLessons from conducting research in an American Indian community: The Pima Indians of Arizona
Lessons from conducting research in an American Indian community: The Pima Indians of Arizona Peter H. Bennett, M.B., F.R.C.P. Scientist Emeritus National Institute of Diabetes and Digestive and Kidney
More informationPREVALENCE OF INSULIN RESISTANCE IN FIRST DEGREE RELATIVES OF TYPE-2 DIABETES MELLITUS PATIENTS: A PROSPECTIVE STUDY IN NORTH INDIAN POPULATION
PREVALENCE OF INSULIN RESISTANCE IN FIRST DEGREE RELATIVES OF TYPE-2 DIABETES MELLITUS PATIENTS: A PROSPECTIVE STUDY IN NORTH INDIAN POPULATION Arvind Kumar, Poornima Tewari, Sibasis S. Sahoo and Arvind
More informationSteroid withdrawal after long-term medication for immunosuppressive therapy in renal transplant patients: adrenal response and clinical implications
Nephrol Dial Transplant (2004) 19: 2615 2621 doi:10.1093/ndt/gfh421 Advance Access publication 27 July 2004 Original Article Steroid withdrawal after long-term medication for immunosuppressive therapy
More informationassociated with serious complications, but reduce occurrences with preventive measures
Wk 9. Management of Clients with Diabetes Mellitus 1. Diabetes Mellitus body s inability to metabolize carbohydrates, fats, proteins hyperglycemia associated with serious complications, but reduce occurrences
More informationA Simplified Indian Diabetes Risk Score for Screening for Undiagnosed Diabetic Subjects
Original Article# A Simplified Indian Diabetes Risk Score for Screening for Undiagnosed Diabetic Subjects V Mohan*, R Deepa*, M Deepa*, S Somannavar*, M Datta** Abstract Aim : The aim of this study was
More informationCHAPTER 5 RENAL TRANSPLANTATION. Editor: Dr Goh Bak Leong
CHAPTER 5 RENAL TRANSPLANTATION Editor: Dr Goh Bak Leong Expert Panel: Dr Goh Bak Leong (Chair) Dato Dr Zaki Morad Mohd Zaher Dato Dr (Mr) Rohan Malek Dr Fan Kin Sing Dr Lily Mushahar Dr Lim Soo Kun Dr
More informationDiabetologia 9 by Springer-Verlag 1979
Diabetologia 16, 25-30 (1979) Diabetologia 9 by Springer-Verlag 1979 Worsening to Diabetes in Men with Impaired Glucose Tolerance ("Borderline Diabetes") R. J. Jarrett, H. Keen, J. H. Fuller, and M. McCartney
More informationCHAPTER 5 RENAL TRANSPLANTATION. Editor: Rosnawati Yahya. Expert Panels: Hooi Lai Seong Ng Kok Peng Suryati Binti Yakaob Wong Hin Seng.
CHAPTER 5 Editor: Roswati Yahya Expert Panels: Hooi Lai Seong Ng Kok Peng Suryati Binti Yakaob Wong Hin Seng Contents 5. Stock and Flow of Rel Transplantation Stock and Flow Transplant Rates 5.2 Recipients
More informationDay-to-day variation of insulin requirements of patients with type 2 diabetes and end-stage renal disease undergoing maintenance hemodialysis
Diabetes Care Publish Ahead of Print, published online March 9, 2010 Day-to-day variation of insulin requirements of patients with type 2 diabetes and end-stage renal disease undergoing maintenance hemodialysis
More informationTHE ANALYZATION OF TIME-BLOOD GLUCOSE CURVE DURING ORAL GLUCOSE TOLERANCE TEST IN PREGNANT WOMEN
Acta Transitional Medicine An International Scientific Journal ISSN: 2521-8662 Volume 1 Issue 2 pp.10-14 June 2018 THE ANALYZATION OF TIME-BLOOD GLUCOSE CURVE DURING ORAL GLUCOSE TOLERANCE TEST IN PREGNANT
More informationCOMPARISON OF HIGHLY SENSITIVE CRP AND SERUM CREATININE AS AN EARLY MARKER OF RENAL IMPAIRMENT
J MEDICINE 2006; 7 : 10-14 COMPARISON OF HIGHLY SENSITIVE CRP AND SERUM CREATININE AS AN EARLY MARKER OF RENAL IMPAIRMENT ROKSANA YEASMIN 1, MD. NIZAMUL HOQUE BHUIYAN 2, SULTANA PARVEEN 1 SHAMIM ARA FERDOUS
More informationOrgan rejection is one of the serious
Original Article Outcomes of Late Corticosteroid Withdrawal after Renal Transplantation in Patients Exposed to Tacrolimus and/or Mycophenolate Mofetil: Meta-Analysis of Randomized Controlled Trials A.
More informationLong-term prognosis of BK virus-associated nephropathy in kidney transplant recipients
Original Article Kidney Res Clin Pract 37:167-173, 2018(2) pissn: 2211-9132 eissn: 2211-9140 https://doi.org/10.23876/j.krcp.2018.37.2.167 KIDNEY RESEARCH AND CLINICAL PRACTICE Long-term prognosis of BK
More informationPreoperative Serum Bicarbonate Levels Predict Acute Kidney Iinjry after Cardiac Surgery
International Journal of ChemTech Research CODEN (USA): IJCRGG, ISSN: 0974-4290, ISSN(Online):2455-9555 Vol.11 No.06, pp 203-208, 2018 Preoperative Serum Bicarbonate Levels Predict Acute Kidney Iinjry
More informationAssociations among Body Mass Index, Insulin Resistance, and Pancreatic ß-Cell Function in Korean Patients with New- Onset Type 2 Diabetes
ORIGINAL ARTICLE korean j intern med 2012;27:66-71 pissn 1226-3303 eissn 2005-6648 Associations among Body Mass Index, Insulin Resistance, and Pancreatic ß-Cell Function in Korean Patients with New- Onset
More informationDiabetes: Staying Two Steps Ahead. The prevalence of diabetes is increasing. What causes Type 2 diabetes?
Focus on CME at the University of University Manitoba of Manitoba : Staying Two Steps Ahead By Shagufta Khan, MD; and Liam J. Murphy, MD The prevalence of diabetes is increasing worldwide and will double
More informationWaist Circumference as an Independent Risk Factor for NODAT
ORIGINAL PAPER ISSN 1425-9524 DOI: 10.12659/AOT.892067 Received: 2014.07.23 Accepted: 2014.10.21 Published: 2015.03.20 Waist Circumference as an Independent Risk Factor for Authors Contribution: Study
More informationElevation of Serum Creatinine: When to Screen, When to Refer. Bruce F. Culleton, MD, FRCPC; and Jolanta Karpinski, MD, FRCPC
Elevation of Serum Creatinine: When to Screen, When to Refer Bruce F. Culleton, MD, FRCPC; and Jolanta Karpinski, MD, FRCPC Presented at the University of Calgary s CME and Professional Development 2006-2007
More informationAssessment of insulin sensitivity and beta-cell function from measurements in the fasting state and during an oral glucose tolerance test
Diabetologia 2000) 43: 1507±1511 Ó Springer-Verlag 2000 Assessment of insulin sensitivity and beta-cell function from measurements in the fasting state and during an oral glucose tolerance test M. Albareda
More informationEquivocal glucose tolerance, insulin sensitivity and β cell function. Alford F et al Diabetologia 7:173, 1971
The pathophysiology of the dysglycaemia of diabetes: A personalised journey from insulin and glucose sensitivities and beta cell function to the incretins familial vs acquired? Frank P Alford Outline of
More informationDiabetes Mellitus. Eiman Ali Basheir. Mob: /1/2019
Diabetes Mellitus Eiman Ali Basheir Mob: 091520385 27/1/2019 Learning Outcomes Discuss the WHO criteria for Diabetes Mellitus diagnosis Describe the steps taken to confirm diagnosis Interpret GTT. Discuss
More informationTime trends in the epidemiology of renal transplant patients with type 1 diabetes mellitus over the last four decades
Nephrol Dial Transplant (2006) 21: 770 775 doi:10.1093/ndt/gfi278 Advance Access publication 9 January 2006 Original Article Time trends in the epidemiology of renal transplant patients with type 1 diabetes
More informationPrevention and management of new-onset diabetes mellitus in kidney transplantation
REVIEW Prevention and management of new-onset diabetes mellitus in kidney transplantation M. Juan Khong, Ch. Ping Chong* Discipline of Clinical Pharmacy, School of Pharmaceutical Sciences, Universiti Sains
More informationTHE KIDNEY AND SLE LUPUS NEPHRITIS
THE KIDNEY AND SLE LUPUS NEPHRITIS JACK WATERMAN DO FACOI 2013 NEPHROLOGY SIR RICHARD BRIGHT TERMINOLOGY RENAL INSUFFICIENCY CKD (CHRONIC KIDNEY DISEASE) ESRD (ENDSTAGE RENAL DISEASE) GLOMERULONEPHRITIS
More informationThese results are supplied for informational purposes only.
These results are supplied for informational purposes only. Prescribing decisions should be made based on the approved package insert in the country of prescription Sponsor/company: sanofi-aventis ClinialTrials.gov
More informationYOU HAVE DIABETES. Angie O Connor Community Diabetes Nurse Specialist 25th September 2013
YOU HAVE DIABETES Angie O Connor Community Diabetes Nurse Specialist 25th September 2013 Predicated 2015 figures are already met 1 in 20 have diabetes:1in8 over 60years old Definite Diagnosis is key Early
More informationNephrology Dialysis Transplantation
Nephrol Dial Transplant (1999) 14: 394 399 Original Article Nephrology Dialysis Transplantation Reduced kidney transplant rejection rate and pharmacoeconomic advantage of mycophenolate mofetil Rudolf P.
More informationNew onset diabetes after transplant (NODAT)
New onset diabetes after transplant (NODAT) Information for families Great Ormond Street Hospital for Children NHS Foundation Trust This information sheet from Great Ormond Street Hospital (GOSH) explains
More informationSUPPLEMENTARY DATA. Supplementary Table S1. Clinical characteristics of the study subjects.*
Supplementary Table S1. Clinical characteristics of the study subjects.* T2D ND n (F/M) 66 (21/45) 25 (7/18) Age (years) 61.8 ± 6.9 49.4 ± 7.3 # Body weight (kg) 95 ± 16 105 ± 13 # Body mass index (kg.
More informationEffect of long-term steroid withdrawal in renal transplant recipients: a retrospective cohort study
NDT Plus (2010) 3 [Suppl 2]: ii32 ii36 doi: 10.1093/ndtplus/sfq064 Effect of long-term steroid withdrawal in renal transplant recipients: a retrospective cohort study Miguel Gonzalez-Molina 1, Miguel Angel
More informationAssociation between Raised Blood Pressure and Dysglycemia in Hong Kong Chinese
Diabetes Care Publish Ahead of Print, published online June 12, 2008 Raised Blood Pressure and Dysglycemia Association between Raised Blood Pressure and Dysglycemia in Hong Kong Chinese Bernard My Cheung,
More informationIdiopathic minimal change nephrotic syndrome in older adults: steroid responsiveness and pattern of relapses
Nephrol Dial Transplant (2003) 18: 1316 1320 DOI: 10.1093/ndt/gfg134 Original Article Idiopathic minimal change nephrotic syndrome in older adults: steroid responsiveness and pattern of relapses Kai-Chung
More informationSoo LIM, MD, PHD Internal Medicine Seoul National University Bundang Hospital
Soo LIM, MD, PHD Internal Medicine Seoul National University Bundang Hospital Agenda Association between Cardiovascular Disease and Type 2 Diabetes Importance of HbA1c Management esp. High risk patients
More informationPrediction of acute renal failure after cardiac surgery: retrospective cross-validation of a clinical algorithm
Nephrol Dial Transplant (2003) 18: 77 81 Original Article Prediction of acute renal failure after cardiac surgery: retrospective cross-validation of a clinical algorithm Bjørn O. Eriksen 1, Kristel R.
More informationBeta-cell dysfunction and glucose intolerance: results from the San Antonio metabolism (SAM) study
Diabetologia (2004) 47:31 39 DOI 10.1007/s00125-003-1263-9 Beta-cell dysfunction and glucose intolerance: results from the San Antonio metabolism (SAM) study A. Gastaldelli 1, 3, E. Ferrannini 1, 2, 3,
More informationType 2 diabetes is occurring in epidemic proportions
The Natural History of Progression From Normal Glucose Tolerance to Type 2 Diabetes in the Baltimore Longitudinal Study of Aging James B. Meigs, 1 Denis C. Muller, 2 David M. Nathan, 3 Deirdre R. Blake,
More informationAssociation of serum phosphate levels with glucose tolerance, insulin sensitivity and insulin secretion in non-diabetic subjects
(2006) 60, 734 739 & 2006 Nature Publishing Group All rights reserved 0954-3007/06 $30.00 www.nature.com/ejcn ORIGINAL ARTICLE Association of serum phosphate levels with glucose tolerance, insulin sensitivity
More informationThe oral meal or oral glucose tolerance test. Original Article Two-Hour Seven-Sample Oral Glucose Tolerance Test and Meal Protocol
Original Article Two-Hour Seven-Sample Oral Glucose Tolerance Test and Meal Protocol Minimal Model Assessment of -Cell Responsivity and Insulin Sensitivity in Nondiabetic Individuals Chiara Dalla Man,
More information